Patel, Darshan P.
Christensen, Michael B.
Hotaling, James M.
Pastuszak, Alexander W.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K08DK115835-01)
Article History
Received: 3 April 2019
Accepted: 17 May 2019
First Online: 12 June 2019
Compliance with ethical standards
:
: DP Patel: None. MB Christensen: None. JM Hotaling: Dr. Hotaling receives research and fellowship support from Boston Scientific and Endo Pharmaceuticals. He holds leadership roles/equity interest in Nanonc, StreamDx, and Andro360 which are all early stage startup companies. AW Pastuszak: Dr. Pastuszak is an advisor to Endo Pharmaceuticals, Boston Scientific, and Antares Pharmaceuticals, and a speaker for Endo Pharmaceuticals and Bayer AG. He is a consultant and receives research and fellowship support from Endo Pharmaceuticals. He holds a leadership position with Woven Health, of which he is also a founder. As this is a review article, no research involving human participants and/or animals was carried out and no informed consent was needed.